← Open Payments lookup

KARA WARSHAW: Open Payments

NPI 1942290200 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,309 in 139 payments from 15 companies in 2025. Trend: 2023 $517 · 2024 $1,117 · 2025 $2,309

Food & beverage: $2,297Education: $12
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.26$383
Alkermes, Inc.23$323
Neurocrine BioSciences, Inc.13$322
ABBVIE INC.21$290
Vanda Pharmaceuticals Inc.12$204
Teva Pharmaceuticals USA, Inc.11$158
Axsome Therapeutics, Inc.10$139
Janssen Pharmaceuticals, Inc4$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$89
E.R. Squibb & Sons, L.L.C.3$70

Products named: INGREZZA, VRAYLAR, ARISTADA, REXULTI, FANAPT, Auvelity, ABILIFY ASIMTUFII, CAPLYTA.

Industry payments across LA — which companies pay providers there.